NOV 16, 2020 11:50 AM PST

Australian COVID-19 vaccine is promising and could be released next year

WRITTEN BY: Heba El Wassef

Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and help life return to normal. With Pfizer announcing recently that its vaccine is proving to be 90% effective against COVID-19, another vaccine candidate is also showing promising results.

Australian vaccine "UQ-CSL V451" that is being developed by a research team at the University of Queensland and biotechnology company CSL Ltd is showing to be safe with the successful production of antibodies against COVID-19 through its phase one clinical trial and is also effective in old people who are more compromised to the virus.

"The initial data is very clear, that the [UQ] vaccine is proving to be safe through phase-one clinical trials and it's proving to produce a positive antibody response,"  Federal Australian Health Minister Greg Hunt says.

"That means it's doing its job. That's particularly so in the elderly, and that is an especially important outcome, given the vulnerability to the elderly around the world from COVID-19.

 

The first phase of the UQ vaccine clinical trial begun last July and involved about 120 volunteers aging from 18-55 years old, with some of the volunteers receiving placebo. It uses a technology called the molecular clamp.

Viruses have a type of proteins called spike proteins on their envelope that helps with the attachment to the host cells membrane; these proteins induce an immune response; therefore, they are an essential target for vaccines. They tend to change their initial native viral form when expressed independently as a part of a vaccine, which leads to an ineffective immune response. The molecular clamp technology helps to overcome this problem by maintaining those proteins' shape to induce a more efficient immune response. 

CSL Ltd company is manufacturing the vaccine and working towards getting approval to start phase-three clinical trials by the end of the year, hoping to make the vaccine available by the third quarter of 2021. CSL also is manufacturing the Oxford-AstraZeneca vaccine in Victoria, Australia. 

By having more than one vaccine candidate around the world that is showing promising results in fighting COVID-19 infection, it gives us some hope that we might be getting closer to the end of this pandemic. 

Sources: 9NEWS, REUTERS, The University Of Queensland

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
DEC 28, 2020
Genetics & Genomics
Mapping Networks of Gene Expression in Cells
DEC 28, 2020
Mapping Networks of Gene Expression in Cells
Every cell contains our whole genome, but not all genes are turned on all the time; gene expression has to be very caref ...
JAN 12, 2021
Immunology
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
JAN 12, 2021
Killer Control: Engineered Stem Cells Dodge Transplant Rejection
The first organ transplant—performed over 60 years ago—was a success because the donor and recipient were id ...
JAN 11, 2021
Immunology
Can Immune cells contribute to Lung Diseases Severity?!
JAN 11, 2021
Can Immune cells contribute to Lung Diseases Severity?!
Macrophages are a type of immune cell that can detect and destruct bacteria, viruses, and harmful materials. They a ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
MAY 06, 2021
Immunology
COVID Vaccines Don't Protect Everyone
MAY 06, 2021
COVID Vaccines Don't Protect Everyone
New research has revealed that COVID-19 vaccines may not work as effectively in those whose immune systems have been neg ...
Loading Comments...